Patient characteristics | Phase A (n=56) | Phase B (n=69) | p Value |
---|---|---|---|
Female | 31/56 (55.4%) | 27/69 (39.1%) | 0.10 |
Age (years) | 6.5 (3;11) | 5 (2;9) | 0.34 |
Phone interview | |||
With mother | 41/55 (74.5%)* | 48/69 (69.6%) | |
With father | 14/55 (25.5%) | 21/69 (30.4%) | |
Medication collected at usual pharmacy? | 46/56 (82.1%) | 46/68 (67.6%)* | 0.10 |
Pharmacy visit at the day of discharge? | 50/56 (89.3%) | 55/67 (82.1%)* | 0.39 |
Prescribed drugs | |||
Number of drugs prescribed | 116 | 138 | |
Mean number/patient | 2.16 (1;7) | 2.06 (1;5) | 0.91 |
Drug categories† | |||
Drug category A | 51/115 (44.3%)* | 72/138 (52.2%) | 0.08 |
Drug category B | 9/115 (7.8%)* | 18/138 (13%) | |
Drug category C | 55/115 (47.8%)* | 48/138 (34.8%) |
*The numerator is different from the sample size because of missing data.
†Category A: analgesics (nervous system), anti-inflammatory and antirheumatic products, topical products for joints and muscular pain and muscle relaxant drugs (ATC classes: N02, M01, M02, M03).
Category B: anti-infective for systemic use (ATC classes: J01, J05).
Category C: all other drugs and treatment.